第 1 到 26 筆結果,共 26 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
2 | 2023 | Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer | Wang, Chi-Liang; Hsu, Kuo-Hsuan; Chang, Ya-Hsuan; CHAO-CHI HO ; CHUN-JU CHIANG ; Chen, Kun-Chieh; Cheung, Yun-Chung; Huang, Pei-Ching; Chen, Yu-Ruei; Chen, Chih-Yi ; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chen, Hsuan-Yu; Yang, Shi-Yi; Li, Yao-Jen; Yang, Tsung-Ying; Tseng, Jeng-Sen; Chuang, Cheng-Yen; Hsiung, Chao A; Chen, Yuh-Min; Huang, Ming-Shyan; CHONG-JEN YU ; KUAN-YU CHEN ; Su, Wu-Chou; Chen, Jeremy J W; SUNG-LIANG YU ; Chen, Chien-Jen; PAN-CHYR YANG ; Tsai, Ying-Huang; Chang, Gee-Chen | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2 | 0 | |
3 | 2023 | Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors | CHUN-TA HUANG ; Lin, Chih-An; Su, Te-Jen; CHING-YAO YANG ; TZU-HSIU TSAI ; CHIA-LIN HSU ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU | BMC cancer | 5 | 2 | |
4 | 2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
5 | 2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
6 | 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 55 | 49 | |
7 | 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
8 | 2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
9 | 2019 | Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; CHIA-CHI LIN ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 27 | 24 | |
10 | 2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
11 | 2018 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum | WEI-YU LIAO ; CHAO-CHI HO ; TZU-HSIU TSAI ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Lung Cancer | 14 | 11 | |
12 | 2018 | Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery | WEN-CHI YANG ; FU-REN XIAO ; JIN-YUAN SHIH ; CHAO-CHI HO ; YA-FANG CHEN ; Tseng H.-M.; KUAN-YU CHEN ; WEI-YU LIAO ; CHONG-JEN YU ; CHIH-HSIN YANG ; SUNG-HSIN KUO ; CHIA-HSIEN CHENG ; PAN-CHYR YANG ; FENG-MING HSU | Radiotherapy and Oncology | 22 | 21 | |
13 | 2017 | Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression | CHUNG-YU CHEN ; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG | Oncotarget | 9 | 9 | |
14 | 2017 | Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer | CHUNG-YU CHEN ; Chen Y.-Y.; MIN-SHU HSIEH ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 25 | 23 | |
15 | 2017 | Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit | YEN-FU CHEN ; JOU-WEI LIN ; CHAO-CHI HO ; CHING-YAO YANG ; CHIA-HAO CHANG ; TAO-MIN HUANG ; CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 17 | 11 | |
16 | 2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; Chia-Chi Lin ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 25 | 25 | |
17 | 2016 | Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer | SHAO-LUN LU ; Feng-Ming Hsu ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHIA-HSIEN CHENG | Case Reports in Oncology | 2 | 0 | |
18 | 2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
19 | 2015 | Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer | WEI-YU LIAO ; CHAO-CHI HO ; HSIN-HAN HOU ; Hsu T.-H.; Tsai M.-F.; KUAN-YU CHEN ; Chen H.-Y.; Lee Y.-C.; CHONG-JEN YU ; Lee C.-H.; PAN-CHYR YANG | Journal of Pathology | 23 | 20 | |
20 | 2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
21 | 2014 | Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer | JIH-HSIANG LEE ; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; YEUN-CHUNG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIA-CHI LIN ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
22 | 2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
23 | 2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
24 | 2012 | Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors | CHIA-LIN HSU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | BMC Cancer | 72 | 66 | |
25 | 2012 | Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer | Yeh C.-T.; Wu T.-H.; Chang P.M.-H.; KUAN-YU CHEN ; Yang C.-N.; Yang S.-C.; CHAO-CHI HO ; Chen C.-C.; Kuo Y.-L.; Lee P.-Y.; Liu Y.-W.; Yen C.-C.; Hsiao M.; Lu P.-J.; Lai J.-M.; Wang L.-S.; Wu C.-H.; Chiou J.-F.; PAN-CHYR YANG ; Huang C.-Y.F. | American Journal of Respiratory and Critical Care Medicine | 163 | 150 | |
26 | 2010 | Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer | Wu J.-Y.; JIN-YUAN SHIH ; CHIH-HSIN YANG ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | International Journal of Cancer | 53 | 45 |